Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-guided radiofrequency ablation plus chemotherapy vs chemotherapy alone in locally advanced pancreatic cancer
TCTR20250117003Phase 3Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jan 2025
- Countries
- 1
01
Overview
Phase 3, randomised trial in pancreatic cancer (PC) (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Jan 2025; status: recruiting.
02
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on TCTR20250117003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250117003.